For more information call
+44 (0)844 736 9016
or email us here
Coming soon - Mawdsleys' Pre-Wholesale division to open additional site in Yorkshire
New app launched to provide offers and retail support to customers
Neon Healthcare have chosen Mawdsleys as their distributor to hospitals in England for their first CMU contract award.
At Mawdsleys we understand that you need to be preparing your plans for the Carter review under the Hospital Pharmacy Transformation Programme (HPTP), but you might need support and information to get started. We have been consulting with key individuals in hospitals about their Lord Carter plans for some time and have started to supply data such as order frequency reports and audit data to help hospital trusts start planning.
Product shortages have been a problem for pharmacies and other healthcare providers for many years. They can have a significant effect on patients and pharmacies; not to mention the NHS as a whole.
The Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for regulating all
medicines and medical devices in the UK, by ensuring they are safe and that those manufacturing,
storing and distributing them are fit to do so. It is compulsory that all UK pharmaceutical manufacturers and distributors undergo a system of licensing and inspection to certify their products are safe, and ensure that they work in compliance with regulatory requirements.
Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan. They provide ground-breaking products and services in more than twenty countries around the world. They have more than 100 years of scientific expertise and draw upon a rich legacy of innovation and a robust pipeline of promising new medicines to help patients.
Daiichi Sankyo approached Mawdsleys’ Pre-Wholesale (MPW) in January 2016; seeking a flexible, cost effective pre-wholesale distributor, that excelled in efficiency.
Survival Pack Update…We are happy to confirm that all of our Pharmacy Cuts Survival Packs have now been packed, sent, signed and delivered to thousands of independent pharmacies across the country.
The impending pharmacy funding cuts is an issue that will impact independent pharmacy the most, making it vital for us to act now! As a company as independent as you are, we at Mawdsleys are here to offer expert advice and support through this challenging time.
As of 1st May 2016, Mawdsleys will become the sole distributor for all Ranbaxy contracted products into the hospital sector (as you are aware, currently hospitals purchase Ranbaxy products directly). All products are now listed on Mawdsleys Online. To ensure continuity of supply all products can still be ordered through Ranbaxy directly until the end of May.
Ever thought about selling medicinal products to other pharmacies and wholesalers? Here’s how we can help:
You may have heard - our customer service number has changed!
For over a decade, Mawdsleys Pre-Wholesale (MPW) has been supporting pharmaceutical companies by providing warehouse and logistics services. Through the outstanding service provided, MPW has grown significantly, becoming a partner of choice for our clients and their customers, and boasts an unrivalled reputation in the market place.
As you will have already heard the Department of Health and NHS England have recently announced a reduction in funding for community pharmacies.
Do you monitor your pharmacy’s financial performance? Do you know how to track your pharmacy’s dispensing business and national services? And can you compare these to the performance of other pharmacies in your area?
Mawdsleys are delighted to be exhibiting at this year’s Healthy Living awards.
Following the success of May’s Stepping Up Together conference, the NPA are delighted to announce part two; which will be held at The Manchester Conference Centre on Sunday September 20th; free of charge.
The contract wave has come back around and we want to share the work load with all of our customers! At Mawdsleys we believe in working together with our customers to help keep your blood pressure down at this stressful time.
Mawdsleys warmly welcomes three new colleagues to support our capability to provide regulatory and pharmaceutical services. Qualified Person (QP) Phil Millward and BDMs Angela McDermott (Clinical Trials Service) and Daniel Belcher (Regulatory and QP Services) all joined the team in May.
We are thrilled to announce that Morningside Pharmaceuticals Ltd have nominated us as distributors from 1st July 2015.
Eat your heart out Simon Cowell, Mawdsley’s very own pharmaceutical services director Omar Shakoor has been selected by the C+D magazine to judge in this year’s awards.
Customers can now receive multi level discounts from manufacturers through Mawdsleys as well as an extra 2% discount on transfer orders.
As part of of our new, clear and competitive OTC service, we are now able to offer our entire Tena range in singles as well as outers.
At Mawdsleys, we have listened to our customers' needs and have launched a new, clear competitive OTC service.
Mawdsleys are delighted to welcome Penry Price to the company to head up the generic purchasing division.
Mawdsleys recognise that pharmacists missing out on prescription payments is a major problem, so are once again working closely with the IPF, to promote a free webinar led by experts from NHSBSA & PSNC.
Mawdsleys have recently announced new appointments in the business which will strengthen further the procurement capacity and support the supply chain for hospital customers.
Julie Clarey has joined Mawdsleys as In House Counsel for the Group.
November 2014 saw the start of one of the largest CMU National Contract Waves.
Mawdsleys are delighted that Niki Hodges has joined the company from Walsall Healthcare NHS Trust.
Mawdsleys have been working hard with manufacturers to provide additional choice for hospitals through new distribution agreements.
In April 2014, HSCIC and NHS England embarked on a Proof of Concept project in order to enable approximately 100 pharmacies access to Summary Care Records (SCR).
Mawdsleys have been nominated by Glenmark to distribute their CMU contracted products in England.
As of 1st November 2014, Mawdsleys have been nominated by Chanelle Medical to distribute their CMU contracted products in England. These products are only available via Mawdsleys and one other wholesaler.
As of 1st November 2014, Mawdsleys have been nominated by Typharm to distribute their CMU contracted products in England. These products are only available via Mawdsleys as a wholesale route and direct with Typharm.
Mawdsleys have proudly donated over 150 presents to the Key 103 Mission Christmas appeal for children living in poverty in Manchester.
Mawdsleys' festive season opening hours
Mawdsleys have been nominated as an additional wholesaler by Sinclair IS to distribute their products in England. This has been in place since August 2014.
As of 1st November 2014, Mawdsleys have been nominated by Genesis Pharma to distribute their CMU contracted products in England. These products will only be available via Mawdsleys and one other wholesaler.
Mawdsleys Unlicensed Medicines will be present at the Neonatal and Paediatric Pharmacists Group annual exhibition and conference on 7th-9th November 2014 at the East Midlands Conference Centre in Nottingham.
New appointments at Mawdsleys will give pharmacies and hospitals an even more competitive wholesale service.
Since 1st August 2014, the full range of Dr Reddy’s UK Ltd NHS contracted products has also been distributed via Mawdsleys to NHS hospitals within England, Scotland & Wales.
At MPW, Mawdsleys’ Third Party Logistics division, we have restructured to ensure the level of service given to our clients and their customers continues to be of the highest possible standard.
Mawdsleys are delighted to announce a new solus hospital distribution agreement with M&A Pharmachem.
Mawdsleys and sister company Positive Solutions are working in partnership with the Independent Pharmacy Federation (IPF), to help independent pharmacists address specific challenges affecting independent pharmacy.
Mawdsleys have recently sent all our hospital customers contract notification packs with all the details they need for the new CMU contracts which started on 1st March & 1st May. As one of the nominated wholesalers for these manufacturer contracts, Mawdsleys pride ourselves, at all times possible, on being in a full stock situation from day one of new contracts waves.
Mawdsleys were praised by The Portland Hospital, the leading private hospital for children, for their commitment to ensuring an urgent unlicensed medicine was delivered to them late in the evening.
Mawdsleys have welcomed on board Aftab Raziq as the new Business Development Manager (BDM) for the Yorkshire area.
Mawdsleys have appointed Steve Bolas as National Sales Manager (Secondary Care). Steve joins us from AAH and his role will be to build upon existing customer relationships, and develop the secondary care proposition as well as looking into new markets and sectors.
Coming soon - Mawdsleys' Pre-Wholesale division to open additional site in Yorkshire
To make room for our growing third party logistics service at Mawdsleys Pre Wholesale (MPW), we have just completed the purchase of a brand new 18 acre site in Yorkshire. Work has commenced on phase one – a 150,000 sq. ft. warehouse complete with full air control systems and a state-of-the-art fit-out to comply with the latest MHRA regulations. Significantly increasing the Mawdsley Group’s resources dedicated to pre-wholesale, the site also allows us to extend the building by a further 150,000 sq. ft. as and when required, so that we can be confident of meeting our customers’ expectations for years to come.
At MPW we have been offering bespoke and highly flexible third party storage and distribution services to the pharmaceutical industry for more than a decade. We pride ourselves on acting as an extension to our clients’ businesses, offering seamless processes and reporting to help them manage their businesses efficiently.
The expansion will give peace of mind to our current clients that we are investing in the future to support their businesses. We will also be in a very strong position to offer our services to new companies.
Helping ensure patients have access to the drugs they need, when they need them.
Select from the following Worldwide sites...×